Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension

CONCLUSION: Initial treprostinil assignment improved survival in the entire data set; those who began treprostinil after a clinical worsening in the placebo arm and tolerated drug to week 48 enjoyed substantial functional …